(Q40541205)

English

Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide

scientific article published on July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide (English)

1 reference

Europe PubMed Central

21 September 2017

2

object named as

Louis J Ignarro

1 reference

Europe PubMed Central

21 September 2017

author name string

Daigo Sumi

1

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

53

1 reference

Europe PubMed Central

21 September 2017

7

1 reference

Europe PubMed Central

21 September 2017

1841-1850

1 reference

Europe PubMed Central

21 September 2017

Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Chemical quantitation of hemoglobin glycosylation: fluorometric detection of formaldehyde released upon periodate oxidation of glycoglobin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Structure of hemoglobin AIc: Nature of the N-terminal β chain blocking group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Nitric oxide synthase inhibition by haem oxygenase decreases macrophage nitric-oxide-dependent cytotoxicity: a negative feedback mechanism for the regulation of nitric oxide production

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Role of protein kinase C in BSA-AGE-mediated inducible nitric oxide synthase expression in RAW 264.7 macrophages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

TGF-beta1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Effect of NADPH oxidase inhibition on endothelial cell ELAM-1 mRNA expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of re

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.2337/DIABETES.53.7.1841

Identifiers

10.2337/DIABETES.53.7.1841

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40541205&oldid=2123604681"